RH Provider
Misha Movahed-Ezazi, M.D.
Specialties:
Anatomic & Clinical Pathology, Neuropathology
Aetna, Inc.
America's Choice Provider Network (ACPN)
AmeriHealth of NJ
CHN Solutions
Clover Health Plans
Devon Health Services/ULLICO
Horizon BCBS Managed Care
Horizon NJ Health
Horizon NJ Total Care (HNJH)
GHI
Medicaid
Medicare
Multiplan/PHCS
Prime Health Services, Inc.
Qual Care HMO
Qual Care PPO
Three Rivers Provider Network
UHC Comm / Oxford
United Healthcare Community Plan (formerly AmeriChoice of NJ, Inc.)
HealthSmart WTC
Wellpoint (formerly AmeriGroup Medicaid HMO/Amerivantage Dual Coordination (HMO SNP))
University Hospital, Newark
M.D., American University of the Caribbean--School of Medicine (01/01/2013-05/20/2017)
Residency: Anatomic & Clinical Pathology, Hartford Hospital, Hartford, CT, USA (07/01/2017-06/30/2021)
Fellowship: Neuropathology, NYU Langone Health, New York, NY, USA (07/01/2021-06/30/2023)
Locations
40.740227437028, -74.192435374758
150 Bergen Street
Newark, NJ 07103
United States
P:
973-972-4300
Provider Biography
Dr. Misha Movahed-Ezazi attended medical school at the American University of the Caribbean in Sint Maarten. She completed her residency training in Anatomical and Clinical Pathology at Hartford Hospital in Connecticut. Following her residency, she completed a 2-year Neuropathology fellowship training program at NYU Langone in Manhattan, where she was extensively trained in diagnosis of tumor and non-tumor disease of the brain and spine, autopsy pathology, molecular pathology, and telepathology/artificial intelligence. Her primary areas of research and expertise is with artificial intelligence and stimulated Raman histology (SRH) in which she conducted a the first pathology based published clinical validation study for SRH-image based intraoperative diagnosis of brain tumors alongside Dr. Daniel Orringer and Dr. Matija Snuderl, whom are experts in the field.